Globeflex Capital »

Keros Therapeutics shares owned by Globeflex Capital

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Globeflex Capital from 13F filings

Historical chart of Globeflex Capital investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Globeflex Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Globeflex Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $418k 38k 11.04

More positions owned by Globeflex Capital

Intercorp Financial Services (IFS)
Phibro Animal Health Corporati*on Cmn Class A (PAHC)
Blue Bird Corp (BLBD)
Exelixis (EXEL)
Catalyst Pharmaceutical Partners (CPRX)
Cirrus Logic (CRUS)
Ypf Sa (YPF)
Allegheny Technologies Incorporated (ATI)
Copa Holdings Sa-class A (CPA)
EnerSys (ENS)
Marex Group (MRX)
Credicorp (BAP)
ESCO Technologies (ESE)
MKS Instruments (MKSI)
Costamare (CMRE)

View all positions for Globeflex Capital

Top funds holding Keros Therapeutics

BlackRock
Vanguard Group
Nantahala Capital Management
Arrowstreet Capital, Limited Partnership
State Street Corporation
Vanguard Capital Management
Madison Avenue Partners
Qube Research & Technologies
OrbiMed Advisors
Jacobs Levy Equity Management
Federated Investors
Vanguard Portfolio Management
Geode Capital Management
Renaissance Technologies
Citadel Advisors

View all funds holding Keros Therapeutics